Expansion Therapeutics: VC Daily : Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs

(marketscreener.com) Good day. Biotechnology startup Expansion Therapeutics Inc. has collected $80 million to hunt for oral medicines that make a significant impact on neurodegenerative diseases. Conventionally, medications have targeted disease proteins. Boston-based Expansion and some other companies are now also developing drugs that target RNA...https://www.marketscreener.com/quote/stock/IONIS-PHARMACEUTICALS-IN-25500637/news/VC-Daily-Expansion-Therapeutics-Gets-80-Million-for-RNA-Targeted-Drugs-36561683/?utm_medium=RSS&utm_content=20210930